ABUS logo

Arbutus Biopharma Corporation (ABUS) Operating Profit

Annual Operating Profit:

-$69.97M+$8.06M(+10.33%)
December 31, 2024

Summary

  • As of today, ABUS annual operating income is -$69.97 million, with the most recent change of +$8.06 million (+10.33%) on December 31, 2024.
  • During the last 3 years, ABUS annual operating profit has risen by +$1.68 million (+2.34%).
  • ABUS annual operating profit is now -1620.98% below its all-time high of $4.60 million, reached on December 31, 2006.

Performance

ABUS Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

Quarterly Operating Profit:

-$8.29M-$10.21M(-533.51%)
September 30, 2025

Summary

  • As of today, ABUS quarterly operating income is -$8.29 million, with the most recent change of -$10.21 million (-533.51%) on September 30, 2025.
  • Over the past year, ABUS quarterly operating profit has increased by +$9.18 million (+52.53%).
  • ABUS quarterly operating profit is now -207.11% below its all-time high of $7.74 million, reached on March 1, 2005.

Performance

ABUS Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

TTM Operating Profit:

-$31.36M+$9.18M(+22.64%)
September 30, 2025

Summary

  • As of today, ABUS TTM operating income is -$31.36 million, with the most recent change of +$9.18 million (+22.64%) on September 30, 2025.
  • Over the past year, ABUS TTM operating profit has increased by +$47.19 million (+60.08%).
  • ABUS TTM operating profit is now -502.73% below its all-time high of $7.79 million, reached on March 1, 2007.

Performance

ABUS TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

ABUS Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+10.3%+52.5%+60.1%
3Y3 Years+2.3%+52.9%+50.1%
5Y5 Years+1.9%+45.1%+42.2%

ABUS Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-10.7%+10.3%-533.5%+61.2%at high+62.0%
5Y5-Year-22.2%+10.3%-533.5%+61.2%at high+62.0%
All-TimeAll-Time-1621.0%+10.3%-207.1%+64.0%-502.7%+62.0%

ABUS Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$8.29M(-533.5%)
-$31.36M(+22.6%)
Jun 2025
-
$1.91M(+114.7%)
-$40.53M(+36.5%)
Mar 2025
-
-$13.03M(-9.0%)
-$63.82M(+8.8%)
Dec 2024
-$69.97M(+10.3%)
-$11.95M(+31.6%)
-$69.97M(+10.9%)
Sep 2024
-
-$17.47M(+18.3%)
-$78.55M(+4.7%)
Jun 2024
-
-$21.37M(-11.4%)
-$82.43M(-2.9%)
Mar 2024
-
-$19.18M(+6.5%)
-$80.08M(-2.6%)
Dec 2023
-$78.03M(-23.4%)
-$20.52M(+3.9%)
-$78.03M(+0.6%)
Sep 2023
-
-$21.35M(-12.3%)
-$78.47M(-5.0%)
Jun 2023
-
-$19.02M(-11.0%)
-$74.71M(-7.4%)
Mar 2023
-
-$17.14M(+18.2%)
-$69.59M(-10.1%)
Dec 2022
-$63.22M(+11.8%)
-$20.95M(-19.1%)
-$63.22M(-0.6%)
Sep 2022
-
-$17.60M(-26.6%)
-$62.87M(-0.1%)
Jun 2022
-
-$13.90M(-29.0%)
-$62.83M(+6.1%)
Mar 2022
-
-$10.77M(+47.7%)
-$66.88M(+6.7%)
Dec 2021
-$71.65M(-25.1%)
-$20.60M(-17.4%)
-$71.65M(-6.6%)
Sep 2021
-
-$17.55M(+2.2%)
-$67.22M(-3.8%)
Jun 2021
-
-$17.95M(-15.4%)
-$64.77M(-8.2%)
Mar 2021
-
-$15.55M(+3.9%)
-$59.84M(-4.5%)
Dec 2020
-$57.27M(+19.7%)
-$16.18M(-7.1%)
-$57.27M(-5.5%)
Sep 2020
-
-$15.10M(-16.0%)
-$54.28M(+5.8%)
Jun 2020
-
-$13.02M(-0.3%)
-$57.61M(+11.9%)
Mar 2020
-
-$12.98M(+1.6%)
-$65.37M(+8.4%)
Dec 2019
-$71.34M(-1.6%)
-$13.18M(+28.4%)
-$71.34M(+3.6%)
Sep 2019
-
-$18.43M(+11.3%)
-$73.98M(-0.4%)
Jun 2019
-
-$20.78M(-9.6%)
-$73.66M(-1.8%)
Mar 2019
-
-$18.95M(-19.8%)
-$72.34M(-3.1%)
Dec 2018
-$70.19M(-0.1%)
-$15.82M(+12.7%)
-$70.17M(+4.9%)
Sep 2018
-
-$18.11M(+7.0%)
-$73.81M(-7.6%)
Jun 2018
-
-$19.46M(-16.0%)
-$68.60M(+0.0%)
Mar 2018
-
-$16.78M(+13.7%)
-$68.62M(+2.2%)
Dec 2017
-$70.13M(-2.7%)
-$19.45M(-50.8%)
-$70.13M(-0.0%)
Sep 2017
-
-$12.90M(+33.8%)
-$70.10M(+4.2%)
Jun 2017
-
-$19.48M(-6.5%)
-$73.17M(+4.6%)
Mar 2017
-
-$18.30M(+5.8%)
-$76.71M(-4.2%)
Dec 2016
-$68.29M(-84.8%)
-$19.42M(-21.5%)
-$73.59M(-24.3%)
Sep 2016
-
-$15.97M(+30.6%)
-$59.22M(-2.6%)
Jun 2016
-
-$23.02M(-51.7%)
-$57.69M(-29.3%)
Mar 2016
-
-$15.18M(-201.1%)
-$44.63M(-20.7%)
Dec 2015
-$36.96M(-12.1%)
-$5.04M(+65.1%)
-$36.96M(+13.4%)
Sep 2015
-
-$14.45M(-45.1%)
-$42.66M(-21.7%)
Jun 2015
-
-$9.96M(-32.6%)
-$35.06M(-1.6%)
Mar 2015
-
-$7.51M(+30.1%)
-$34.52M(-4.7%)
Dec 2014
-$32.97M(-171.3%)
-$10.75M(-57.0%)
-$32.97M(-33.7%)
Sep 2014
-
-$6.84M(+27.4%)
-$24.66M(-15.0%)
Jun 2014
-
-$9.42M(-58.2%)
-$21.44M(-41.9%)
Mar 2014
-
-$5.96M(-144.5%)
-$15.11M(-23.8%)
Dec 2013
-$12.15M(+6.0%)
-$2.44M(+32.7%)
-$12.20M(+22.2%)
Sep 2013
-
-$3.62M(-17.1%)
-$15.69M(-13.3%)
Jun 2013
-
-$3.09M(-1.1%)
-$13.85M(-4.0%)
Mar 2013
-
-$3.06M(+48.4%)
-$13.32M(-3.3%)
Dec 2012
-$12.93M
-$5.92M(-232.7%)
-$12.89M(-42.6%)
Sep 2012
-
-$1.78M(+30.3%)
-$9.04M(-0.7%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$2.56M(+2.9%)
-$8.98M(+11.7%)
Mar 2012
-
-$2.63M(-26.8%)
-$10.16M(+4.6%)
Dec 2011
-$10.62M(-65.7%)
-$2.08M(-21.0%)
-$10.65M(+31.4%)
Sep 2011
-
-$1.72M(+54.1%)
-$15.54M(-44.3%)
Jun 2011
-
-$3.74M(-19.9%)
-$10.77M(+2.8%)
Mar 2011
-
-$3.12M(+55.2%)
-$11.08M(+9.7%)
Dec 2010
-$6.41M(+23.0%)
-$6.96M(-327.8%)
-$12.26M(-60.5%)
Sep 2010
-
$3.06M(+175.4%)
-$7.64M(+41.5%)
Jun 2010
-
-$4.05M(+5.9%)
-$13.05M(-19.6%)
Mar 2010
-
-$4.30M(-84.0%)
-$10.91M(-30.2%)
Dec 2009
-$8.32M(+12.5%)
-$2.34M(+0.8%)
-$8.38M(-16.7%)
Sep 2009
-
-$2.36M(-23.4%)
-$7.18M(+4.5%)
Jun 2009
-
-$1.91M(-7.9%)
-$7.52M(+30.2%)
Mar 2009
-
-$1.77M(-54.9%)
-$10.77M(-9.2%)
Dec 2008
-$9.51M(-490.7%)
-$1.14M(+57.6%)
-$9.86M(-14.2%)
Sep 2008
-
-$2.70M(+47.8%)
-$8.64M(-97.3%)
Jun 2008
-
-$5.16M(-498.7%)
-$4.38M(-556.0%)
Mar 2008
-
-$862.40K(-1178.0%)
$960.30K(-60.4%)
Dec 2007
$2.43M(-47.1%)
$80.00K(-94.9%)
$2.42M(+4.0%)
Sep 2007
-
$1.57M(+789.6%)
$2.33M(-50.3%)
Jun 2007
-
$176.10K(-70.7%)
$4.68M(-39.8%)
Mar 2007
-
$600.30K(+4450.0%)
$7.79M(+64.7%)
Dec 2006
$4.60M(+490.8%)
-
-
Dec 2006
-
-$13.80K(-100.4%)
$4.73M(+177.0%)
Sep 2006
-
$3.92M(+19.6%)
$1.71M(+136.5%)
Jun 2006
-
$3.28M(+233.4%)
-$4.67M(+59.3%)
Mar 2006
-
-$2.46M(+19.0%)
-$11.49M(-790.4%)
Dec 2005
-$1.18M(+94.6%)
-
-
Dec 2005
-
-$3.03M(-23.5%)
-$1.29M(+81.2%)
Sep 2005
-
-$2.46M(+30.6%)
-$6.86M(+25.7%)
Jun 2005
-
-$3.54M(-145.7%)
-$9.23M(+8.8%)
Mar 2005
-
$7.74M(+190.0%)
-$10.13M(+53.7%)
Dec 2004
-$21.88M(+31.8%)
-
-
Dec 2004
-
-$8.61M(-78.2%)
-$21.86M(+4.5%)
Sep 2004
-
-$4.83M(-8.9%)
-$22.89M(+10.3%)
Jun 2004
-
-$4.44M(-11.4%)
-$25.52M(-21.0%)
Mar 2004
-
-$3.98M(+58.7%)
-$21.09M(-23.3%)
Dec 2003
-$32.08M(-15.5%)
-
-
Dec 2003
-
-$9.64M(-29.2%)
-$17.10M(-1.4%)
Sep 2003
-
-$7.46M(+20.6%)
-$16.86M(+39.3%)
Dec 2002
-$27.79M(-64.7%)
-
-
Dec 2002
-
-$9.40M(-20.6%)
-$27.79M(-12.3%)
Sep 2002
-
-$7.80M(-56.2%)
-$24.75M(-18.4%)
Jun 2002
-
-$4.99M(+10.9%)
-$20.89M(-4.5%)
Mar 2002
-
-$5.60M(+11.9%)
-$20.00M(-16.7%)
Dec 2001
-$16.87M(-53.0%)
-
-
Dec 2001
-
-$6.36M(-61.3%)
-$17.13M(-59.0%)
Sep 2001
-
-$3.94M(+3.9%)
-$10.78M(-57.7%)
Jun 2001
-
-$4.10M(-49.9%)
-$6.83M(-149.9%)
Mar 2001
-
-$2.73M
-$2.73M
Dec 2000
-$11.03M(-28.5%)
-
-
Dec 1999
-$8.58M(+12.9%)
-
-
Dec 1998
-$9.85M(-30.7%)
-
-
Dec 1997
-$7.54M
-
-

FAQ

  • What is Arbutus Biopharma Corporation annual operating income?
  • What is the all-time high annual operating profit for Arbutus Biopharma Corporation?
  • What is Arbutus Biopharma Corporation annual operating profit year-on-year change?
  • What is Arbutus Biopharma Corporation quarterly operating income?
  • What is the all-time high quarterly operating profit for Arbutus Biopharma Corporation?
  • What is Arbutus Biopharma Corporation quarterly operating profit year-on-year change?
  • What is Arbutus Biopharma Corporation TTM operating income?
  • What is the all-time high TTM operating profit for Arbutus Biopharma Corporation?
  • What is Arbutus Biopharma Corporation TTM operating profit year-on-year change?

What is Arbutus Biopharma Corporation annual operating income?

The current annual operating profit of ABUS is -$69.97M

What is the all-time high annual operating profit for Arbutus Biopharma Corporation?

Arbutus Biopharma Corporation all-time high annual operating income is $4.60M

What is Arbutus Biopharma Corporation annual operating profit year-on-year change?

Over the past year, ABUS annual operating income has changed by +$8.06M (+10.33%)

What is Arbutus Biopharma Corporation quarterly operating income?

The current quarterly operating profit of ABUS is -$8.29M

What is the all-time high quarterly operating profit for Arbutus Biopharma Corporation?

Arbutus Biopharma Corporation all-time high quarterly operating income is $7.74M

What is Arbutus Biopharma Corporation quarterly operating profit year-on-year change?

Over the past year, ABUS quarterly operating income has changed by +$9.18M (+52.53%)

What is Arbutus Biopharma Corporation TTM operating income?

The current TTM operating profit of ABUS is -$31.36M

What is the all-time high TTM operating profit for Arbutus Biopharma Corporation?

Arbutus Biopharma Corporation all-time high TTM operating income is $7.79M

What is Arbutus Biopharma Corporation TTM operating profit year-on-year change?

Over the past year, ABUS TTM operating income has changed by +$47.19M (+60.08%)
On this page